Medications are supposed to heal, and the vast majority do their job safely. But drugs can also cause serious harm when something goes wrong, when a medication is contaminated in manufacturing, when a company fails to disclose known and serious side effects, or when the risks were understated to doctors and patients. A dangerous drug case is a product liability claim, and like other product cases it can rest on a manufacturing defect or a failure to warn. Drug cases also carry special rules that make experienced, informed handling important from the start.
Two main ways a drug can be defective
How a drug can be defective
Drug cases tend to fall into two main patterns. The first is a manufacturing problem, most often contamination, where the drug that reached the patient was not what it was supposed to be because something went wrong in production. The second, and more common, is a failure to warn, where the drug itself was made correctly but the company did not adequately disclose a known danger. Many of the most significant drug cases are warning cases, because the central question is often whether the manufacturer forthrightly told doctors and patients what it knew about a serious risk, or whether it downplayed or concealed it to protect sales. When a company’s own records show it understood a danger and failed to warn, that can be powerful evidence.
Brand-name drugs, generic drugs, and federal preemption
One of the most important and least understood features of drug cases is that federal law treats brand-name and generic medications very differently. For brand-name drugs, the courts have generally allowed state-law failure-to-warn claims to go forward, on the reasoning that the manufacturer could have strengthened its warning on its own. For generic drugs, the picture changes. Because federal law requires a generic drug’s label to match the brand-name label, the courts have held that many claims against generic manufacturers, including failure-to-warn and design claims, are barred by federal preemption, since the generic maker could not lawfully have changed the label by itself. This distinction can be decisive. The same injury from the same medicine may support a claim if the patient took the brand-name version and run into a preemption barrier if they took the generic. Because of that, one of the first steps in a drug case is identifying exactly which product was involved and how federal law treats it. Over-the-counter drugs carry their own duties as well, and because they are sold directly to consumers, their warnings generally must reach the consumer rather than a prescribing physician.
The learned intermediary rule
As with medical devices, prescription drug cases are shaped by the learned intermediary doctrine. The manufacturer’s duty to warn generally runs to the prescribing physician rather than directly to the patient, on the theory that the physician is positioned to weigh the risks and benefits for a particular patient. This does not eliminate the duty to warn. It focuses it on whether the company gave physicians the adequate, honest information they needed to advise their patients. A drug maker that gave doctors incomplete or misleading information about a serious risk can still be responsible, and proving what the company knew and what it told the medical community is often at the center of these cases.
Recalls, contamination, and federal rules
A drug recall can be important to a case, though it does not decide one by itself. A recall can be evidence that a problem existed and was recognized, which can help show the danger was real and known. Whether or not a drug was recalled, the question remains whether it was defective or inadequately labeled and whether that caused the harm. Drug cases also involve federal regulation through the FDA, and in some circumstances federal law can affect which claims may proceed. This area is complex and drug-specific, and evaluating it is one of the first steps in these cases, which is another reason they call for careful handling.
What to do if a medication harmed you
If you believe a medication caused you serious harm, get the medical care you need first. Keep the medication along with its packaging, labeling, and any information you received, and if you still have the bottle or the pills, preserve them. Note what you were prescribed, the dose, when you took it, and who prescribed it. Then have the situation reviewed promptly, because drug cases involve special rules and deadlines, and the sooner the case is evaluated, the more of the evidence can be preserved.
When a drug harms many people
Dangerous drug cases often involve not one patient but many, because a drug reaches enormous numbers of people, and a hidden risk can harm many of them in the same way. This sometimes leads to coordinated litigation, where similar claims are handled together for efficiency while each person’s case remains their own. Whether a case stands alone or joins a larger group, the objective does not change: to show that the drug was defective or inadequately labeled and that it caused this person’s specific harm, and to recover for that person’s actual losses. Part of handling these cases well is making sure an individual client and their particular injuries are never lost in a crowd of claimants.
What a dangerous drug case can recover
The harm from a dangerous drug can be severe and lasting, and the damages reflect that. A Florida claim can seek the cost of past and future medical care, lost income and lost earning capacity, and compensation for the pain, disability, and loss the drug caused. Where a defective drug caused a death, the surviving family may bring a wrongful death claim for their own losses. What the case is worth depends on the harm and the strength of the proof, not on any figure promised at the outset.
Why these cases take a team, and why my background fits
Drug cases combine complex medicine and science, dense regulatory questions, and a pharmaceutical company with vast resources, and they turn on technical documents and the cross-examination of the company’s experts. That is the kind of document-heavy, detail-driven litigation I have built my career on. I represent injured people, not drug companies or insurers, and because these cases require significant resources and specialized knowledge, I take them on together with experienced co-counsel who focus on this work, pairing my trial and cross-examination experience with their depth. I handle your case personally, and I am prepared to take it to a jury when that is what it takes. Learn more about my background.
Common Questions
Can I sue a drug company for a dangerous medication?
Sometimes. A prescription or over-the-counter drug can be the basis of a claim when it was defectively made, when its known dangers were not adequately disclosed, or when it was contaminated, and that caused injury. These cases carry special rules, so an early evaluation matters.
What makes a drug defective?
A drug can be defective through a manufacturing problem such as contamination, or through a failure to warn about known risks and side effects. Drug cases most often turn on warnings, because the question is frequently whether the company forthrightly disclosed what it knew about the danger.
How does the learned intermediary rule apply to drugs?
For prescription drugs, the manufacturer’s duty to warn generally runs to the prescribing physician rather than directly to the patient. A failure-to-warn claim often focuses on whether the company gave physicians adequate, honest information about the drug’s risks.
What if the drug was recalled?
A recall does not by itself decide a case, but it can be important evidence that a problem existed. Whether the drug was recalled or not, the question remains whether it was defective or inadequately labeled and whether that caused your harm. A recall can help show the danger was real and known.
What should I do if a medication harmed me?
Get medical care, keep the medication and its packaging and labeling if you still have them, and note what you were prescribed, when, and by whom. Then have the situation reviewed promptly, because drug cases involve special rules and deadlines that make early attention important.
This page is general information about Florida product liability law, not legal advice, and it does not create an attorney-client relationship. The governing authorities include Florida’s strict product liability doctrine, adopted in West v. Caterpillar Tractor Co., 336 So. 2d 80 (Fla. 1976), and reaffirmed in Aubin v. Union Carbide Corp., 177 So. 3d 489 (Fla. 2015), the comparative fault statute in section 768.81, the two-year limitations period in section 95.11(5)(a), and the twelve-year statute of repose in section 95.031. Federal preemption also shapes drug claims: brand-name failure-to-warn claims generally survive under Wyeth v. Levine, 555 U.S. 555 (2009), while claims against generic manufacturers are largely preempted under PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011). Every case is different, and past results do not guarantee a similar outcome. The hiring of a lawyer is an important decision that should not be based solely on advertisements.
